Share

Clinical Studies (1)

  • De Vito : Study aims to evaluate the efficacy and safety of molnupiravir in treating COVID-19 in a real-life cohort

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to